Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CLRB US Equity

Cellectar Biosciences, Inc.Health Care · Pharmaceutical Preparations · CIK 1279704 · FY ends Dec 31
$2.62
+0.03 (+1.16%)
USD · as of 2026-08-19 · marketstack

Short interest· FINRA consolidated · settlement 2026-07-31

6 settlement cycles
Shares short175K
% of shares out1.8%
Days to cover3.9
Δ vs 2026-07-15-12.3%
▲ 778K shares shortline top = 3.9d to cover2026-05-15: 778K short · 1.0d to cover2026-052026-05-29: 258K short · 1.1d to cover2026-052026-06-15: 57K short · 1.0d to cover2026-062026-06-30: 194K short · 1.2d to cover2026-062026-07-15: 199K short · 1.7d to cover2026-072026-07-31: 175K short · 3.9d to cover2026-07

bars = shares short · line = days to cover (own scale)

SettlementShares shortΔ vs priorAvg daily volumeDays to cover
2026-07-31174,829-12.3%44,4673.9
2026-07-15199,436+2.6%118,5711.7
2026-06-30194,336+238.8%156,9631.2
2026-06-1557,356-77.8%153,0601.0
2026-05-29258,202-66.8%236,0601.1
2026-05-15777,622+3288.2%5,137,9241.0

FINRA Rule 4560 · twice monthly, published ~a week later.

Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.